Paradoxically, PAI-1 may participate in the pathophysiology of cancer progression, because elevated PAI-1 expression in primary tumors is associated with poor prognosis and substantially increased risk of recurrence [1], [2]. This evidence concerns the gene SERPINE1 and cancer.